Date:04/12/2008 URL: http://www.thehindu.com/2008/12/04/stories/2008120455771600.htm
Back



Business

Ranbaxy inks deal with BioPro Pharma


NEW DELHI: Ranbaxy Laboratories on Wednesday has entered into an exclusive licensing agreement with the U.S.-based BioPro Pharmaceuticals for marketing and distributing its drug ‘Gliadel Wafer’ used for treating brain tumor. The company has also received import permission for marketing ‘Gliadel Wafer’ in India.

© Copyright 2000 - 2009 The Hindu